Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I

被引:1
|
作者
Can, Ngoc Thi Bich [1 ]
Tran, Dien Minh [1 ]
Bui, Thao Phuong [1 ]
Nguyen, Khanh Ngoc [1 ]
Nguyen, Hoang Huy [2 ]
Nguyen, Tung Van [2 ]
Hwu, Wuh-Liang [3 ]
Tomatsu, Shunji [4 ]
Vu, Dung Chi [1 ]
机构
[1] Vietnam Natl Childrens Hosp, 18-879 Lathanh, Hanoi 100000, Vietnam
[2] Vietnam Acad Sci & Technol, Inst Genome Res, 18 Hoang Quoc Viet, Hanoi 100000, Vietnam
[3] Natl Taiwan Univ Hosp, Dept Pediat, 8 Chung Shan South Rd, Taipei 10041, Taiwan
[4] Nemours Alfred I duPont Hosp Children, DuPont Expt Stn, Bldg E400 5205,200 Powder Mill Rd, Wilmington, DE 19803 USA
来源
LIFE-BASEL | 2021年 / 11卷 / 11期
关键词
alpha-L-iduronidase (IDUA) gene; IDUA gene mutation; mucopolysaccharidosis type I; PRE-MESSENGER-RNA; IDENTIFICATION; MUTATIONS; PREDICTION; MANAGEMENT;
D O I
10.3390/life11111162
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder caused by deleterious mutations in the alpha-L-iduronidase (IDUA) gene. Until now, MPS I in Vietnamese has been poorly addressed. Five MPS I patients were studied with direct DNA sequencing using Illumina technology confirming pathogenic variants in the IDUA gene. Clinical characteristics, additional laboratory results, and family history were collected. All patients have presented with the classical characteristic of MPS I, and alpha-L-iduronidase activity was low with the accumulation of glycosaminoglycans. Three variants in the IDUA gene (c.1190-10C > A (Intronic), c.1046A > G (p.Asp349Gly), c.1862G > C (p.Arg621Pro) were identified. The c.1190-10C > A variant represents six of the ten disease alleles, indicating a founder effect for MPS I in the Vietnamese population. Using biochemical and genetic analyses, the precise incidence of MPS I in this population should accelerate early diagnosis, newborn screening, prognosis, and optimal treatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients
    Matte, U
    Yogalingam, G
    Brooks, D
    Leistner, S
    Schwartz, I
    Lima, L
    Norato, DY
    Brum, JM
    Beesley, C
    Winchester, B
    Giugliani, R
    Hopwood, JJ
    MOLECULAR GENETICS AND METABOLISM, 2003, 78 (01) : 37 - 43
  • [42] Laronidase for the treatment of mucopolysaccharidosis type I
    Clarke, Lorne A.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (06) : 755 - 768
  • [43] Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I
    Giugliani, Roberto
    Muschol, Nicole
    Keenan, Hillary A.
    Dant, Mark
    Muenzer, Joseph
    ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (07) : 674 - 679
  • [44] Mucopolysaccharidosis Type I in the Russian Federation and Other Republics of the Former Soviet Union: Molecular Genetic Analysis and Epidemiology
    Voskoboeva, E. Yu
    Bookina, T. M.
    Semyachkina, A. N.
    Mikhaylova, S. V.
    Vashakmadze, N. D.
    Baydakova, G. V.
    Zakharova, E. Yu
    Kutsev, S. I.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [45] Laronidase for treating mucopolysaccharidosis type I
    El Dib, R. P.
    Pastores, G. M.
    GENETICS AND MOLECULAR RESEARCH, 2007, 6 (03): : 667 - 674
  • [46] A few challenges in mucopolysaccharidosis type I
    Bay, Luisa
    Amartino, Hernan
    Antacle, Alejandra
    Arberas, Claudia
    Berretta, Adriana
    Botto, Hugo
    Cazalas, Mariana
    Copiz, Adriana
    De Cunto, Carmen
    Drelichman, Guillermo
    Espada, Graciela
    Eiroa, Hernan
    Fainboim, Alejandro
    Fano, Virginia
    Guelber, Norberto
    Maffey, Alberto
    Parisi, Claudio
    Pereyra, Marcela
    Remondino, Rodrigo
    Schenone, Andrea
    Specola, Norma
    Staciuk, Raquel
    Zuccaro, Graciela
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2021, 119 (03): : E193 - E201
  • [47] Advances in the treatment of mucopolysaccharidosis type I
    Muenzer, J
    Fisher, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19): : 1932 - 1934
  • [48] Mucopolysaccharidosis type I in the Cuban population
    Menéndez-Sainz, C
    Zaldívar-Muñoz, C
    González-Quevedo, A
    REVISTA DE NEUROLOGIA, 2003, 37 (06) : 525 - 528
  • [49] Molecular characterization of mucopolysaccharidosis type IVA patients in the Andean region of Colombia
    Pachajoa, Harry
    Acosta, Maria Amparo
    Almeciga-Diaz, Carlos J.
    Ariza, Yoseth
    Diaz-Ordonez, Lorena
    Caicedo-Herrera, Gabriela
    Cuartas, Daniel
    Nastasi-Catanese, Jose Antonio
    Ramirez-Montano, Diana
    Silva, Yiseth Katherine
    Moreno, Lina
    Satizabal, Jose
    Garcia, Natalia
    Montoya, Jorge
    Prada, Carlos
    Porras, Gloria
    Velasco, Harvy
    Candelo, Estephania
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2021, 187 (03) : 388 - 395
  • [50] Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III
    Kim, Min-Sun
    Yang, Aram
    Noh, Eu-Seon
    Kim, Chiwoo
    Bae, Ga Young
    Lim, Han Hyuk
    Park, Hyung-Doo
    Cho, Sung Yoon
    Jin, Dong-Kyu
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):